Clinical Trials Report Unveiled in Texas

Clinical Trials Report Unveiled in Texas

03.26.13 | By

Dr. Curtis Triplett, an assistant professor of diabetes medicine at the University of Texas Health Science Center at San Antonio Texas Diabetes Institute, is a clinician on the front lines of the fight against diabetes. At a news conference Monday at the Capitol in Austin, he made clear what he and so many other diabetes researchers and clinicians are aiming for as they conduct clinical trials of new medicines -- an eventual cure. With quiet pride, he talked about his work against a scourge that afflicts 1 in 10 Texans and about 20 million Americans nationwide.A speaker at the rollout of a new report "Research in Your Backyard: Pharmaceutical Clinical Trials in Texas," he lent a personal touch and demonstrated the dedication of the clinicians who are behind the impressive numbers in the report. He is intelligent, patient and committed to the challenge that he has chosen as his life's work. He has all of the traits needed to effectively pursue clinical research.

Supporting young researchers like Dr. Triplett and the hundreds of institutions they work for all over the state is what is on the minds of State Senator Bob Deuell and Representative Jim Murphy, who are sponsoring research and development tax credit legislation currently pending in the Legislature. Both attended Monday's news conference on "Research in Your Backyard" to spotlight the report's impressive numbers and how those statistics are, to a large degree, the result of ongoing state support for broad-based R and D, including biopharmaceutical clinical trials.

Biopharmaceutical companies have responded to this balance of state incentives, combined with an enviable biomedical research infrastructure featuring hundreds of university medical schools and science centers, local hospitals and private clinical research facilities and dedicated clinicians like Dr. Triplett. 8,254 clinical trials of new medicines have been conducted in the state since 1999. These trials have helped to advance patient care because they target not only the most debilitating chronic diseases -- asthma, heart disease, stroke, cancer, diabetes and mental illnesses -- but also an array of other less prevalent medical conditions. The clinical trials have boosted the Lone Star State economy because biopharmaceutical companies, by and large, have used local research institutions to conduct the trials, making them a steady revenue source and an opportunity for gifted local researchers to get in involved in cutting-edge biomedical science. Clinical trials in Texas have become a constructive long-term partnership involving biopharmaceutical companies, the state and hundreds of innovative local research institutions.


Hide Comments

More On PhRMA — powered by PhRMApedia


Cost in Context